| 去甲氧柔红霉素治疗急性白血病的临床疗效观察 |
| |
| 引用本文： | 曾晓颖 陈瑜. 去甲氧柔红霉素治疗急性白血病的临床疗效观察[J]. 中国癌症杂志, 1998, 8(1): 72-74 |
| |
| 作者姓名： | 曾晓颖 陈瑜 |
| |
| 摘 要： | 目的 观察和比较去甲氧柔红霉素治疗急性的初治、复发以及难治性白血病的临床疗效.方法34例急性白血病应用去甲氧柔红霉素辅以其它药物的联合化疗,分为初治组、复发组和难治组三组进行疗效观察比较.结果总有效率达70.6%,初治组与复发组疗效比较有显著性差异(P<0.05),初治组与难治组比较疗效有显著性差异(P<0.01).结论 去甲氧柔红霉素是一种新型、有效的治疗急性白血病的药物.
|
| 关 键 词： | 急性白血病 去甲氧柔红霉素 化疗 |
EFFICACY OF IDARUBICIN IN THE TREATMENT OF ACUTE LEUKEMIA: A CLINICAL OBSERVATION |
| |
| Zeng Xiaoying,Chen Yu,Zhou Li,et al.. EFFICACY OF IDARUBICIN IN THE TREATMENT OF ACUTE LEUKEMIA: A CLINICAL OBSERVATION[J]. China Oncology, 1998, 8(1): 72-74 |
| |
| Authors: | Zeng Xiaoying Chen Yu Zhou Li et al. |
| |
| Affiliation: | Zeng Xiaoying,Chen Yu,Zhou Li,et al. Department of Hematology,Rui Jin Hospital,Shanghai Second Medical University 200025 |
| |
| Abstract: | PURPOSEObservation of clinical efficacy of idarubicin in the treatment of patients with both newly-diagnosed and relapsed/refractory acute leukemia. METHODS 34 patients of acute leukemia enrolled in this study are classified into 3 groups: newly-diagnosed, relapsed and refractory group. All patients are treated with combination chemotherapy composed of idarubicin and other agents. RESULTS The response rate for all patients is 70. 6% while the result in newly-diagnosed group is superior to both relapsed and refractory group (P<0. 05 and P< 0. 01). CONCLUSION Idarubicin is a very effective agent in the treatment of acute leukemia. |
| |
| Keywords: | Acute leukemia Idarubicin Chemotherapy |
| 本文献已被 维普 等数据库收录！ |
|
